These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8117432)

  • 41. Laboratory evaluation of the UniCel DxI 800 analyser (Beckman Coulter) for detecting HBV and HCV serological markers.
    Miedouge M; Legrand-Abravanel F; Lalanne C; Saune K; Izopet J
    J Clin Virol; 2009 Feb; 44(2):134-7. PubMed ID: 19110466
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Immunological markers for early diagnosis and foresight of HBV related fulminant hepatitis].
    Onji M
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):498-501. PubMed ID: 12442434
    [No Abstract]   [Full Text] [Related]  

  • 43. [Laboratory diagnosis of viral hepatitis B and C].
    Burek V
    Acta Med Croatica; 2005; 59(5):405-12. PubMed ID: 16381235
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
    Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Significance of "anti HBC alone" serological profile in 284 patients suspicious of being infected with hepatitis B virus].
    Berrajah-Fki L; Ben Halima S; Guermazi F; Hammami A; Karray-Hakim H
    Ann Biol Clin (Paris); 2006; 64(5):451-5. PubMed ID: 17040876
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis B virus e antigen specific epitopes and limitations of commercial anti-HBe immunoassays.
    Baumeister MA; Medina-Selby A; Coit D; Nguyen S; George-Nascimento C; Gyenes A; Valenzuela P; Kuo G; Chien DY
    J Med Virol; 2000 Mar; 60(3):256-63. PubMed ID: 10630956
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
    Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC
    Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of a new automated assay for hepatitis B surface antigen (HBsAg) detection VIDAS HBsAg Ultra.
    Weber B; Van der Taelem-Brulé N; Berger A; Simon F; Geudin M; Ritter J
    J Virol Methods; 2006 Jul; 135(1):109-17. PubMed ID: 16567005
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changing epidemiology of HCV and HBV infections in Northern Italy: a survey in the general population.
    Fabris P; Baldo V; Baldovin T; Bellotto E; Rassu M; Trivello R; Tramarin A; Tositti G; Floreani A
    J Clin Gastroenterol; 2008; 42(5):527-32. PubMed ID: 18277889
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
    Amini S; Mahmoodi MF; Andalibi S; Solati AA
    J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Occult hepatitis B virus infection.
    Allain JP
    Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [R-PHA and PHA methods for the detection of HBeAg and anti-HBe].
    Horiike N; Onji M; Ogawa Y; Kanaoka M; Kajino K; Ohta Y
    Rinsho Byori; 1984 Mar; 32(3):287-90. PubMed ID: 6737740
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical, laboratory and liver histology of HBsAg-positive volunteer blood donors in Belo Horizonte, State of Minas Gerais, Brazil].
    Paz MO; Galizzi Filho J; Simonetti JP; Simonetti SR; de Santana ZM; Barbosa MM; de Carvalho DG; Toppa NH
    Rev Hosp Clin Fac Med Sao Paulo; 1998; 53(6):311-6. PubMed ID: 10413947
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies.
    Gandhi RT; Wurcel A; Lee H; McGovern B; Shopis J; Geary M; Sivamurthy R; Sax PE; Ukomadu C
    J Infect Dis; 2005 May; 191(9):1435-41. PubMed ID: 15809901
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Radioimmunoassay and enzyme immunoassay methods for detecting viral hepatitis markers.
    Hanson MR; Polesky HF
    Am J Clin Pathol; 1983 Oct; 80(4 Suppl):590-3. PubMed ID: 6353906
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Preparation and application of the national reference panel for hepatitis B virus DNA].
    Wu X; Wang YC; Zhang HY; Yang J; Yu Y; Lin JX; Gu WJ; Lan HY; Li HM
    Zhonghua Gan Zang Bing Za Zhi; 2003 Jul; 11(7):402-4. PubMed ID: 12890340
    [TBL] [Abstract][Full Text] [Related]  

  • 58. What you need to know: interpreting hepatitis B viral markers.
    Tan CK
    Singapore Med J; 1998 Mar; 39(3):139-40. PubMed ID: 9632977
    [No Abstract]   [Full Text] [Related]  

  • 59. Evidence for a dynamic host-parasite relationship in e-negative hepatitis B carriers.
    Tedder RS; Ijaz S; Gilbert N; Barbara JA; Corden SA; Gilson RJ; Boxall EH
    J Med Virol; 2002 Dec; 68(4):505-12. PubMed ID: 12376958
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clearance of hepatitis B surface antigen after bone marrow transplantation: role of adoptive immunity transfer.
    Lau GK; Lok AS; Liang RH; Lai CL; Chiu EK; Lau YL; Lam SK
    Hepatology; 1997 Jun; 25(6):1497-501. PubMed ID: 9185774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.